273 related articles for article (PubMed ID: 10763104)
1. [The effect of GABA-positive agents on the formation of morphine dependence and on the manifestations of a withdrawal syndrome].
Belozertseva IV; Andreev BV
Eksp Klin Farmakol; 2000; 63(1):19-23. PubMed ID: 10763104
[TBL] [Abstract][Full Text] [Related]
2. Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of mu-opioid receptors in prepubertal male and female mice.
Diaz SL; Barros VG; Antonelli MC; Rubio MC; Balerio GN
Synapse; 2006 Aug; 60(2):132-40. PubMed ID: 16715492
[TBL] [Abstract][Full Text] [Related]
3. Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms.
Pałucha A; Brański P; Pilc A
Pol J Pharmacol; 2004; 56(6):863-6. PubMed ID: 15662102
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of morphine withdrawal signs by a GABAB receptor agonist in the locus coeruleus of rats.
Riahi E; Mirzaii-Dizgah I; Karimian SM; Sadeghipour HR; Dehpour AR
Behav Brain Res; 2009 Jan; 196(1):11-4. PubMed ID: 18634832
[TBL] [Abstract][Full Text] [Related]
6. [Effect of psychotropic agents on the manifestation of the morphine abstinence syndrome in mice].
Patkina NA; Evartau EE
Farmakol Toksikol; 1980; 43(1):19-23. PubMed ID: 7189719
[TBL] [Abstract][Full Text] [Related]
7. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
Pinelli A; Cighetti G; Trivulzio S
Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
[TBL] [Abstract][Full Text] [Related]
8. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
Hodgson SR; Hofford RS; Norris CJ; Eitan S
Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
[TBL] [Abstract][Full Text] [Related]
9. Influence of sweet tasting solutions on opioid withdrawal.
Jain R; Mukherjee K; Singh R
Brain Res Bull; 2004 Dec; 64(4):319-22. PubMed ID: 15561466
[TBL] [Abstract][Full Text] [Related]
10. [The effect of ritanserin on the formation and expression of an opiate abstinence syndrome].
Verbitskaia EV; Kudriashova MF
Eksp Klin Farmakol; 1997; 60(1):19-21. PubMed ID: 9162274
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade.
Hamdy MM; Noda Y; Miyazaki M; Mamiya T; Nozaki A; Nitta A; Sayed M; Assi AA; Gomaa A; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):263-70. PubMed ID: 15196794
[TBL] [Abstract][Full Text] [Related]
12. Potential usefulness of single-dose acute physical dependence on and tolerance to morphine for the evaluation of narcotic antagonists.
Jacob JJ; Barthelemy CD; Tremblay EC; Colombel MC
Adv Biochem Psychopharmacol; 1973; 8(0):299-318. PubMed ID: 4800176
[No Abstract] [Full Text] [Related]
13. [Neurotropin suppression of the manifestations of the naloxone-provoked withdrawal syndrome in morphine-dependent rats].
Sudakov SK; Konstantinopol'skiĭ MA; Surkova LA; Tiurina IV; Konishi J; Yumia H
Farmakol Toksikol; 1991; 54(4):16-8. PubMed ID: 1786813
[TBL] [Abstract][Full Text] [Related]
14. Preventing withdrawal syndrome.
Whedon M
Nursing; 1995 Dec; 25(12):59. PubMed ID: 8552343
[No Abstract] [Full Text] [Related]
15. Blockade by narcotic drugs of naloxone-precipitated jumping in morphine-dependent mice.
Iorio LC; Deacon MA; Ryan EA
J Pharmacol Exp Ther; 1975 Jan; 192(1):58-63. PubMed ID: 1168251
[TBL] [Abstract][Full Text] [Related]
16. The dopamine release inhibitor CGS 10746B blocks conditioned physical signs of morphine withdrawal.
Rodríguez-Arias M; Aguilar MA; Miñarro J
Addict Biol; 2003 Jun; 8(2):167-72. PubMed ID: 12850775
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of morphine withdrawal signs by the GABA(B) receptor agonist baclofen.
Bexis S; Ong J; White J
Life Sci; 2001 Dec; 70(4):395-401. PubMed ID: 11798009
[TBL] [Abstract][Full Text] [Related]
18. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
Zarrindast MR; Mohajeri S
Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
[TBL] [Abstract][Full Text] [Related]
19. Effect of acupuncture on naloxone-precipitated withdrawal syndrome in morphine-experienced rats: the mediation of GABA receptors.
Lee JH; Kim HY; Jang EY; Choi SH; Han CH; Lee BH; Yang CH
Neurosci Lett; 2011 Oct; 504(3):301-5. PubMed ID: 21982805
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of morphine dependence by naloxone in acutely dependent mice.
Sofuoglu M; Sato J; Takemori AE
J Pharmacol Exp Ther; 1990 Sep; 254(3):841-6. PubMed ID: 2395116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
